“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

CoMMiTMenT beneficiary ORX at BioJapan 2016

November 07, 2016

CoMMiTMenT beneficiary ORX was invited to exhibit at the Scandinavian booth at the 18th BioJapan conference in Yokohama, Japan, which took place from 12 to 14 October, 2016. ORX was proud to follow the invitation, which was an excellent opportunity to present their latest developments to an international audience in many face-to-face meetings and also distribute the CoMMiTMenT project flyer to visitors to the booth.

BioJapan is an annual international conference and Asia's premier partnering event for the Japanese and global biotechnology industry's top business development and licensing professionals, alliance management professionals, R&D personnel and biotech company executives. It plays an important role in facilitating interaction between Japanese and global companies and organisations and stimulating new business opportunities. This year’s event attracted more than 15,000 visitors.